Axsome Therapeutics, Inc. (AXSM) quarterly cash flow statement — complete operating, investing & financing history
Axsome Therapeutics, Inc. (AXSM) cash flow statement — 13-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -9.47M | -32.95M | -20.7M | -18.65M | 1.05M | -32.42M | -43.38M | -26.2M | -18.63M | -30.11M | -53.47M | -30.36M | -53.55M | -55.35M | -5.82M | -27.56M | -22.76M | -33.54M | -32.65M | -28.84M |
| Operating CF Margin % | -3.65% | -15.09% | -10.83% | -9.52% | 0.61% | -21.61% | -35.71% | -22.06% | -17.78% | -34.54% | -71.29% | -42.45% | -92.65% | -118.52% | -6.15% | -113.1% | -135.09% | -380.23% | - | - |
| Operating CF Growth % | -1005.26% | -1.63% | 52.28% | 28.81% | 105.61% | -7.68% | 18.88% | 13.7% | 65.21% | 45.6% | -818.52% | -10.15% | -135.29% | -65.04% | 82.17% | 4.43% | 15.01% | -32.07% | -19.98% | -40.32% |
| Net Income | -12.88M | -51.31M | -64.54M | -28.56M | -47.23M | -47.97M | -59.41M | -74.91M | -64.6M | -79.34M | -68.36M | -98.65M | -62.2M | -67.17M | -11.22M | -61.24M | -44.82M | -41.44M | -39.63M | -33.98M |
| Depreciation & Amortization | 3.06M | 2.89M | 2.37M | 2.27M | 2.41M | 2.25M | 2.13M | 2.07M | 2.06M | 1.99M | 1.83M | 1.74M | 1.74M | 1.38M | 1.98M | 2.02M | 1.96M | 1.27M | 311.7K | 307.41K |
| Stock-Based Compensation | 26.36M | 27.15M | 23.44M | 22.73M | 23.1M | 24.61M | 23.31M | 21.99M | 21.66M | 21.38M | 20.19M | 18.91M | 14.84M | 15.92M | 12.94M | 10.77M | 9.2M | 10.16M | 7.6M | 5.89M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -617K | 0 | 617K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.34M | -475K | 985K | -8.27M | 13.98M | 3.02M | 746K | 11.85M | 38.32M | 2.98M | -324K | 44.83M | 1.03M | 7.13M | 105K | 4.19M | 119.56K | -658.25K | 8.34K | -34.29K |
| Working Capital Changes | -24.66M | -11.2M | 17.05M | -6.83M | 8.78M | -14.33M | -10.15M | 12.8M | -16.07M | 22.88M | -6.81M | 3.42M | -8.96M | -13.23M | -9.63M | 16.7M | 10.78M | -2.87M | -939.03K | -1.03M |
| Change in Receivables | -65.66M | -26.4M | -26.6M | -27.96M | 2.32M | -37.43M | -19.4M | -17.91M | -3.75M | -18.91M | -6.62M | -16.41M | -11.01M | -22.62M | -7.09M | -17.4M | -4.13M | -16.17M | 0 | 0 |
| Change in Inventory | -4.26M | -5.89M | -4.87M | -3.49M | -4.99M | -1.78M | -249K | -4.14M | 1.29M | 690K | -105K | -4.89M | 2.81M | -1.05M | -4.42M | -4.54M | -1.01M | 277K | 0 | 0 |
| Change in Payables | 17.11M | -27.73M | 41.16M | 11.31M | -37.4M | 5.97M | 13.66M | 7.74M | 2.91M | 7.55M | 13.11M | 11.58M | -13.86M | 7.19M | -2.83M | 25.76M | -6.59M | 6.84M | -554.22K | -232.35K |
| Cash from Investing | -197K | -450K | -121K | -71K | -58K | -13K | -338K | -30K | -90K | -52K | -98K | -7K | -371K | -133K | -71K | -180.86K | -66.06K | -53.24M | -213.74K | -307.55B |
| Capital Expenditures | -197K | 121K | -121K | -71K | -58K | -13K | -338K | -30K | 150K | -52K | -98K | -7K | -371K | -133K | -71K | -180.86K | -66.06K | -241.46K | -213.74K | 307.55K |
| CapEx % of Revenue | 0.08% | 0.06% | 0.06% | 0.04% | 0.03% | 0.01% | 0.28% | 0.03% | 0.14% | 0.06% | 0.13% | 0.01% | 0.64% | 0.28% | 0.08% | 0.74% | 0.39% | 2.74% | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -53M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -571K | 0 | 0 | 0 | 0 | 0 | 0 | -240K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -307.55B |
| Cash from Financing | 3.67M | 48.15M | 2.99M | 16.39M | 21.27M | 34.54M | 29.27M | 14.24M | 30.41M | 14.38M | -1.19M | -2K | 33.37M | 246.08M | 51.56M | 1.07M | 176.95M | 75.46M | 31.1M | 690.48K |
| Debt Issued (Net) | 0 | -1.21M | -672K | -541K | -664K | -6.14M | -401K | -330K | -311K | -186K | -163K | 855K | -856K | 30M | 55M | 0 | 0 | 45M | 0 | 0 |
| Equity Issued (Net) | 10.06M | 55.24M | 16.23M | 20.91M | 25.28M | 43.78M | 19.65M | 16.42M | 13.1M | 17.78M | 2.5M | 1.15M | 33.75M | 225M | 0 | 2.83M | 178.05M | 32.55M | 31.19M | 1.09M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -6.38M | -5.88M | -12.56M | -3.99M | -3.35M | -3.09M | 10.02M | -1.84M | 17.61M | -3.22M | -3.52M | -2M | 476K | -8.92M | -3.44M | -1.76M | -1.1M | -2.09M | -88.59K | -401.04K |
| Net Change in Cash | -5.99M | 14.74M | -17.83M | -2.34M | 22.26M | 2.11M | -14.44M | -11.99M | 11.68M | -15.78M | -54.75M | -30.37M | -20.55M | 190.6M | 45.67M | -26.68M | 154.13M | -11.31M | -1.77M | -28.15M |
| Free Cash Flow | -9.67M | -32.83M | -20.82M | -18.72M | 988K | -32.44M | -43.71M | -26.23M | -18.48M | -30.16M | -53.56M | -30.37M | -53.92M | -55.48M | -5.89M | -27.74M | -22.82M | -33.78M | -32.87M | -28.53M |
| FCF Margin % | -3.72% | -15.03% | -10.89% | -9.55% | 0.58% | -21.62% | -35.99% | -22.09% | -17.64% | -34.6% | -71.42% | -42.46% | -93.3% | -118.81% | -6.23% | -113.84% | -135.49% | -382.97% | - | - |
| FCF Growth % | -1078.34% | -1.22% | 52.37% | 28.62% | 105.35% | -7.54% | 18.39% | 13.62% | 65.72% | 45.64% | -809.11% | -9.46% | -136.24% | -64.25% | 82.07% | 2.76% | 15.58% | -32.92% | -20.63% | -38.69% |
| FCF per Share | -0.18 | -0.64 | -0.41 | -0.37 | 0.02 | -0.66 | -0.89 | -0.54 | -0.38 | -0.63 | -1.13 | -0.64 | -1.14 | -1.27 | -0.14 | -0.64 | -0.55 | -0.86 | -0.86 | -0.76 |
| FCF Conversion (FCF/Net Income) | 0.74x | 0.64x | 0.32x | 0.65x | -0.02x | 0.68x | 0.73x | 0.35x | 0.29x | 0.38x | 0.78x | 0.31x | 0.86x | 0.82x | 0.52x | 0.45x | 0.51x | 0.81x | 0.82x | 0.85x |
| Interest Paid | 0 | 0 | 2.93M | 3.05M | 3.22M | 3.77M | 4.59M | 4.75M | 5.02M | 5.01M | 4.9M | 4.87M | 4.73M | 3.92M | 3.22M | 2.57M | 2.53M | 1.47M | 1.12M | 1.14M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |